ICRP 123: Be9 - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz Be9. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of heavy ion.xls, sheet Be9
Znormalizowana macierz danych ICRP 123 dla cząstki Be9: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 4392 z 4392 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 15.9 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 14.3 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 17.4 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1430 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1740 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 1 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 31.6 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 28.7 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 34.6 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2870 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3460 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 2 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 47.4 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 42.9 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 51.9 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4290 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5190 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 3 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 78.4 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.7 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 70.9 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.7 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 85.9 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.7 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7090 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.7 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8590 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.7 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 5 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 196 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 195 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 198 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.84 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.641 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 291 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 264 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 236 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.99 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.35 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.24 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.3 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16600 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.4 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.7 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.12 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 228 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.2 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.1 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.1 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.18 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 10 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 290 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 293 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 286 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.01 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.09 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.106 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.126 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.102 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.11 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0909 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.145 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 315 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0945 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.116 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.316 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.09 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.6 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.3 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.118 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.126 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12.6 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.182 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18700 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22300 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.6 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.83 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 287 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.7 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0981 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.168 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.095 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.2 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.127 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.5 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.93 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.102 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0912 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.11 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0997 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.115 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0917 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.12 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0963 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.59 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.59 |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 14 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 465 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 482 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 447 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.22 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.24 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.395 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.645 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.648 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.672 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.432 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.665 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.278 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.589 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.692 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.272 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.447 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.629 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.76 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.387 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.554 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.3 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.58 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.659 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.497 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.3 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.34 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24900 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26700 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.3 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.84 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.343 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.236 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.6 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.366 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.333 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.656 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.392 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.639 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.384 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.3 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.08 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.4 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.61 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.727 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.21 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.581 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.07 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.354 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.258 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.522 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.587 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.411 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.839 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.492 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Be9 | Be-9 | 4 | 9 | 20 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 979 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1180 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 777 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.5 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.46 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6950 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4600 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.01 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.34 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.98 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.99 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.05 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.77 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.94 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.09 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.4 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.13 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.86 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.71 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.954 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.86 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.5 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.3 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.42 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.74 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 738 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.3 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21600 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21900 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.5 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.06 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.37 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.08 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.08 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.99 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.86 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.62 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 423 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.73 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 160 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.5 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.67 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.68 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.36 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.26 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.73 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.63 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.98 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.6 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.06 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.65 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22100 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.8 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22100 |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Be9 | Be-9 | 4 | 9 | 30 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1950 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2450 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1460 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 317 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 366 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15000 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9590 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.1 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.2 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.57 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.4 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.8 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.2 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3770 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.01 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.04 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.5 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.52 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 277 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 309 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.37 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 847 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 802 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.5 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5430 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2330 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15500 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 622 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.11 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.46 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3910 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1980 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.26 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.38 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.99 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.05 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.75 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.14 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1780 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 681 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1570 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.81 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.12 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.17 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.83 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.54 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.2 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.54 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.16 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 301 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 179 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16900 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16900 |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Be9 | Be-9 | 4 | 9 | 50 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 3030 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 3430 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2630 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1750 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15600 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12300 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 368 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 273 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 225 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 466 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7480 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.3 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 240 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 291 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4680 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6210 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.4 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3370 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4040 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3700 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2280 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9890 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7110 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12100 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12200 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.5 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.9 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6980 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4010 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.2 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.4 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.9 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.7 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.8 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3010 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2550 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4870 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3260 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2680 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.3 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26.7 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26.1 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.9 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.7 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.6 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.9 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2630 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1870 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 75 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 4460 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 4650 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 4270 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2970 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3150 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13700 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12000 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3010 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3120 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2130 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2880 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3520 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8430 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.9 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2770 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1560 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7820 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8400 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4040 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7110 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6720 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5470 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6920 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8970 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10900 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2750 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2490 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 265 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8270 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4760 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1860 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 278 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3690 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3560 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7800 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6610 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3730 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5270 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.2 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.4 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.3 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2400 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7050 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5550 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.9 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12500 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12500 |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 100 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7550 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7390 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7710 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6670 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7160 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10000 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9650 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7280 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7350 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9050 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10400 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5950 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7930 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7440 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2010 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5910 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7480 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4280 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6650 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7780 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7760 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4510 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12500 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9820 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10200 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6490 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7310 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5130 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3890 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11900 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11300 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3790 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4900 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5530 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7690 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6800 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6500 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7450 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9830 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12400 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11300 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2530 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3410 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5460 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6280 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6870 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8350 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7090 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7400 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11200 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11200 |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 150 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 9790 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 9340 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 10200 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9380 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10400 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8990 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9740 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9120 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10900 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11700 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8880 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9940 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7690 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9580 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8790 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9610 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11000 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12200 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9970 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11100 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8150 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8390 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11100 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13500 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10700 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11200 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10000 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10400 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9410 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6970 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11500 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12100 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8370 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10700 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11500 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8330 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9870 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9450 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10200 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10700 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11800 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11000 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8750 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9760 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8660 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9610 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8650 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9200 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9140 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10400 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10300 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11600 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11600 |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2 | |
| Be9 | Be-9 | 4 | 9 | 200 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8960 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8950 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8970 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8750 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8870 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9190 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9210 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8830 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8950 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9000 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8960 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9030 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9130 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8470 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8970 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9140 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8830 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8900 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9250 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9440 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8630 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8910 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8770 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8820 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8770 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9090 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9030 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8940 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8800 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8890 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9050 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9070 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8850 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9370 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9230 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9150 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9360 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9670 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8910 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8650 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8950 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9050 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8910 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8980 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8870 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9090 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8780 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9030 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9200 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9070 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9070 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8700 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8940 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9180 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8850 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9560 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9330 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8860 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8860 |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 300 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6580 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6540 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6630 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6470 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6620 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6680 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6600 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6540 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6590 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6530 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6640 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6500 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6550 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6940 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6170 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6850 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6420 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6860 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6650 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6660 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6870 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6840 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6670 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6860 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6750 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6800 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6670 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5670 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6840 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6950 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6970 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6740 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6810 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6650 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6420 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6380 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6550 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6550 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6640 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6660 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6670 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6740 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6820 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6300 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6470 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6610 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6910 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6610 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6600 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6450 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6420 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6430 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6540 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7260 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7260 |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 500 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6110 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6120 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6060 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6040 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6460 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6320 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6150 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6000 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6070 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5760 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6390 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6030 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5920 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6320 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6260 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6270 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5900 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5770 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5900 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6160 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6120 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6080 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5820 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5820 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6060 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6120 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6130 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6130 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6070 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5870 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6090 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6120 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6120 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5680 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5930 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5980 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6060 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6130 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6260 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6080 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5920 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6320 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5660 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 700 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6020 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6090 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6000 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5980 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6150 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6280 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5940 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6100 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5900 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5940 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6320 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6020 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6070 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6340 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5920 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6170 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6150 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5970 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5980 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5920 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5960 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6330 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5600 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5850 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5860 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6040 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5930 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6040 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6150 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6090 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5940 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5950 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6110 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5990 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6040 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5630 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5780 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6060 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6050 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5830 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5960 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6070 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6090 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6020 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5720 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6260 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6010 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5290 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5290 |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 1000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6440 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6540 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6340 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6570 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6390 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6270 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6530 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6410 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6370 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6600 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6190 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6790 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6620 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6570 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6410 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6860 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6170 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6670 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6690 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6440 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6320 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6220 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6180 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6260 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6360 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6270 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6000 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5890 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6330 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6610 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6270 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5690 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6780 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6310 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6410 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6590 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6530 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6590 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6440 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6370 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6280 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6430 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6070 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6710 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6350 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6630 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6570 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6600 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6590 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6360 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6690 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6130 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6160 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6160 |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 2000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6770 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6760 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 6780 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6860 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6830 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6470 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6950 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7050 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6710 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6710 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6840 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6900 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6500 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6940 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6950 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6920 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6730 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6930 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6190 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7080 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7000 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6500 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6290 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6590 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6480 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6400 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6210 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6170 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6870 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6760 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7300 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6980 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6630 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6460 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7060 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6800 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6770 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6710 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6990 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6830 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6830 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6770 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6640 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6650 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6130 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7110 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7020 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6740 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7360 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7030 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7080 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7130 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6560 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6520 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6500 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6300 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6300 |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 3000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7180 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7230 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 7130 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7470 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7290 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6970 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6840 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7180 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7280 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7220 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7050 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7510 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7450 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7130 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7320 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7590 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7550 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7100 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6740 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6400 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6420 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7360 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6890 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6970 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6910 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6840 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6970 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6330 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6510 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6460 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7410 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7280 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7600 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8170 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6890 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6270 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7870 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7960 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7370 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7280 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7720 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7440 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7310 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7180 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7030 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6980 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7420 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6580 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7890 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7350 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7260 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7640 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7410 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7650 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7330 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7330 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7200 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6750 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6570 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6570 |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 5000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8430 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8580 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8270 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8390 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7930 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7630 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8900 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8660 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8570 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8270 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8880 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8160 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8240 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8460 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8900 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8600 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8650 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8150 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7820 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8010 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9330 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8500 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8130 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7830 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8270 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7490 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7990 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8130 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7460 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7200 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8540 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9050 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9370 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8150 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8140 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9340 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9230 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8530 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8350 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9150 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8960 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8790 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8380 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8220 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8060 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8090 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7690 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9400 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8940 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9580 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8520 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9100 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8920 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8240 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7500 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8390 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7120 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7120 |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 10000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8930 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 9310 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8550 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9460 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8620 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8110 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7850 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10000 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8850 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9130 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8590 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8350 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9140 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9760 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9390 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8240 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9550 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9010 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9030 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7030 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9430 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8720 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8150 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8660 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7630 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8240 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8360 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7900 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7550 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9260 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8620 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9670 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9040 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8010 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8480 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9130 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9310 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8300 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9620 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8700 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9500 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8740 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8750 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8360 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8240 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8010 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9890 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8310 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9330 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9410 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9080 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8290 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8510 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9530 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8040 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7380 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7380 |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 20000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 13000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 13300 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 12700 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13700 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13200 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13700 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13300 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11400 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10300 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11200 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14500 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12200 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11600 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15700 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14200 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14400 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13100 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11900 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13200 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8000 |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 50000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 17400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 18000 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 16800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18000 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13700 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20000 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20700 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18300 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16900 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15900 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17300 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17900 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15600 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13300 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11600 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13300 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20500 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20400 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20500 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16300 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14700 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14600 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18000 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19600 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18100 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19700 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17500 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16200 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15500 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12800 |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |
| Be9 | Be-9 | 4 | 9 | 100000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 |